Survival of chronic myeloid leukemia patients in comparison to the general population in the tyrosine kinase inhibitors era: A US population-based study

被引：4
|
作者：
Jamy, Omer [1 ]
Godby, Richard [2 ]
Sarmad, Rehan [1 ]
Costa, Luciano J. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 07期
关键词：
D O I：
10.1002/ajh.26195
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E265 / E268
页数：4
相关论文
共 50 条
  • [11] Cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors in Taiwan: a nationwide population-based study
    Yang, Yu-Chien
    Huang, Ru-Yu
    Tsai, Hui-Jen
    Li, Po-Chih
    Yang, Yi-Hsin
    Hsieh, Kun-Pin
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (09) : 1312 - 1321
  • [12] Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
    Gale, Robert Peter
    Goldman, John M.
    ACTA HAEMATOLOGICA, 2013, 130 (03) : 192 - 195
  • [13] Outcomes of pregnancy in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Kondo, Takeshi
    Matsuki, Eri
    Takaku, Tomoiku
    Watanabe, Naoki
    Yoshida, Chikashi
    Okada, Masaya
    Murai, Kazunori
    Kodama, Takashi
    Takahashi, Naoto
    Kimura, Shinya
    Matsumura, Itaru
    CANCER, 2025, 131 (01)
  • [14] Survival of Mantle Cell Lymphoma in the Era of Bruton Tyrosine Kinase Inhibitors: A Population-Based Analysis
    Di, Mengyang
    Cui, Can
    Kothari, Shalin K.
    Zeidan, Amer M.
    Podoltsev, Nikolai
    Neparidze, Natalia
    Shallis, Rory M.
    Wang, Rong
    Ma, Xiaomei
    Huntington, Scott F.
    BLOOD, 2021, 138
  • [15] Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis
    Di, Mengyang
    Cui, Can
    Kothari, Shalin K.
    Zeidan, Amer M.
    Podoltsev, Nikolai A.
    Neparidze, Natalia
    Shallis, Rory M.
    Wang, Rong
    Ma, Xiaomei
    Huntington, Scott F.
    BLOOD ADVANCES, 2022, 6 (11) : 3339 - 3342
  • [16] Survival for older patients with acute myeloid leukemia: a population-based study
    Oran, Betul
    Weisdorf, Daniel J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (12): : 1916 - 1924
  • [17] Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France
    Pajiep, Marie
    Conte, Cecile
    Huguet, Francoise
    Gauthier, Martin
    Despas, Fabien
    Lapeyre-Mestre, Maryse
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [18] Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013
    Tumas Beinortas
    Ilma Tavorienė
    Tadas Žvirblis
    Rolandas Gerbutavičius
    Mindaugas Jurgutis
    Laimonas Griškevičius
    BMC Cancer, 16
  • [19] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary Beth
    Pierce, Sherry A.
    Jabbour, Elias J.
    Cortes, Jorge E.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 545 - 552
  • [20] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Koji Sasaki
    Hagop M. Kantarjian
    Susan O’Brien
    Farhad Ravandi
    Marina Konopleva
    Gautam Borthakur
    Guillermo Garcia-Manero
    William G. Wierda
    Naval Daver
    Alessandra Ferrajoli
    Koichi Takahashi
    Preetesh Jain
    Mary Beth Rios
    Sherry A. Pierce
    Elias J. Jabbour
    Jorge E. Cortes
    International Journal of Hematology, 2019, 109 : 545 - 552
12345